Elevated Selenoprotein P Levels in Thalassemia Major Patients
Previous studies have measured selenium levels and glutathione peroxidase 3 (GPX3) activity in patients with thalassemia major (TM). However, Selenoprotein P (SEPP), which is responsible for the storage and transport of selenium, has not been studied in thalassemia patients. This study aims to corre...
Saved in:
| Published in | Archives of medical research Vol. 53; no. 5; pp. 508 - 515 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Inc
01.07.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Previous studies have measured selenium levels and glutathione peroxidase 3 (GPX3) activity in patients with thalassemia major (TM). However, Selenoprotein P (SEPP), which is responsible for the storage and transport of selenium, has not been studied in thalassemia patients. This study aims to correlate thyroid functions of TM patients with their SEPP and GPX3 levels.
Eighty subjects (40 controls, 40 TM patients) were included in this study. GPX3 and SEPP concentrations were measured in all subjects using sandwich ELISA. Iron, ferritin, urinary iodine, thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH), anti-thyroid peroxidase (anti-TPO), and anti-human thyroglobulin (anti-hTG) concentrations were also measured.
Mean SEPP concentration was higher in the TM group compared to the control group. A slight elevation in GPX3 levels was also observed in thalassemia patients, yet it was not statistically significant. In both TM patients and controls, ferritin was inversely correlated with free T4 concentration and GPX3 was inversely correlated with free T4 and T3 concentrations. There was also a negative correlation between SEPP and TSH concentrations in healthy subjects.
This is the first study, which has measured SEPP concentrations in thalassemia patients. SEPP levels were higher in TM patients compared to controls. Correlations between thyroid hormones and selenoproteins may indicate that selenium is necessary for thyroid function. Detailed studies are required to elaborate the role of SEPP in thyroid metabolism in thalassemia patients. |
|---|---|
| AbstractList | Previous studies have measured selenium levels and glutathione peroxidase 3 (GPX3) activity in patients with thalassemia major (TM). However, Selenoprotein P (SEPP), which is responsible for the storage and transport of selenium, has not been studied in thalassemia patients. This study aims to correlate thyroid functions of TM patients with their SEPP and GPX3 levels.INTRODUCTIONPrevious studies have measured selenium levels and glutathione peroxidase 3 (GPX3) activity in patients with thalassemia major (TM). However, Selenoprotein P (SEPP), which is responsible for the storage and transport of selenium, has not been studied in thalassemia patients. This study aims to correlate thyroid functions of TM patients with their SEPP and GPX3 levels.Eighty subjects (40 controls, 40 TM patients) were included in this study. GPX3 and SEPP concentrations were measured in all subjects using sandwich ELISA. Iron, ferritin, urinary iodine, thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH), anti-thyroid peroxidase (anti-TPO), and anti-human thyroglobulin (anti-hTG) concentrations were also measured.MATERIALS AND METHODSEighty subjects (40 controls, 40 TM patients) were included in this study. GPX3 and SEPP concentrations were measured in all subjects using sandwich ELISA. Iron, ferritin, urinary iodine, thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH), anti-thyroid peroxidase (anti-TPO), and anti-human thyroglobulin (anti-hTG) concentrations were also measured.Mean SEPP concentration was higher in the TM group compared to the control group. A slight elevation in GPX3 levels was also observed in thalassemia patients, yet it was not statistically significant. In both TM patients and controls, ferritin was inversely correlated with free T4 concentration and GPX3 was inversely correlated with free T4 and T3 concentrations. There was also a negative correlation between SEPP and TSH concentrations in healthy subjects.RESULTSMean SEPP concentration was higher in the TM group compared to the control group. A slight elevation in GPX3 levels was also observed in thalassemia patients, yet it was not statistically significant. In both TM patients and controls, ferritin was inversely correlated with free T4 concentration and GPX3 was inversely correlated with free T4 and T3 concentrations. There was also a negative correlation between SEPP and TSH concentrations in healthy subjects.This is the first study, which has measured SEPP concentrations in thalassemia patients. SEPP levels were higher in TM patients compared to controls. Correlations between thyroid hormones and selenoproteins may indicate that selenium is necessary for thyroid function. Detailed studies are required to elaborate the role of SEPP in thyroid metabolism in thalassemia patients.CONCLUSIONThis is the first study, which has measured SEPP concentrations in thalassemia patients. SEPP levels were higher in TM patients compared to controls. Correlations between thyroid hormones and selenoproteins may indicate that selenium is necessary for thyroid function. Detailed studies are required to elaborate the role of SEPP in thyroid metabolism in thalassemia patients. Previous studies have measured selenium levels and glutathione peroxidase 3 (GPX3) activity in patients with thalassemia major (TM). However, Selenoprotein P (SEPP), which is responsible for the storage and transport of selenium, has not been studied in thalassemia patients. This study aims to correlate thyroid functions of TM patients with their SEPP and GPX3 levels. Eighty subjects (40 controls, 40 TM patients) were included in this study. GPX3 and SEPP concentrations were measured in all subjects using sandwich ELISA. Iron, ferritin, urinary iodine, thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH), anti-thyroid peroxidase (anti-TPO), and anti-human thyroglobulin (anti-hTG) concentrations were also measured. Mean SEPP concentration was higher in the TM group compared to the control group. A slight elevation in GPX3 levels was also observed in thalassemia patients, yet it was not statistically significant. In both TM patients and controls, ferritin was inversely correlated with free T4 concentration and GPX3 was inversely correlated with free T4 and T3 concentrations. There was also a negative correlation between SEPP and TSH concentrations in healthy subjects. This is the first study, which has measured SEPP concentrations in thalassemia patients. SEPP levels were higher in TM patients compared to controls. Correlations between thyroid hormones and selenoproteins may indicate that selenium is necessary for thyroid function. Detailed studies are required to elaborate the role of SEPP in thyroid metabolism in thalassemia patients. |
| Author | Ozturk, Zeynep Kupesiz, Alphan Talibova, Gunel Parlak, Mesut |
| Author_xml | – sequence: 1 givenname: Gunel surname: Talibova fullname: Talibova, Gunel organization: Department of Pediatric Hematology, Faculty of Medicine, Akdeniz University, Antalya, Turkey – sequence: 2 givenname: Zeynep orcidid: 0000-0002-0598-4294 surname: Ozturk fullname: Ozturk, Zeynep organization: Department of Pediatric Hematology, Faculty of Medicine, Akdeniz University, Antalya, Turkey – sequence: 3 givenname: Mesut surname: Parlak fullname: Parlak, Mesut organization: Department of Pediatric Endocrinology, Faculty of Medicine, Akdeniz University, Antalya, Turkey – sequence: 4 givenname: Alphan orcidid: 0000-0001-8827-5567 surname: Kupesiz fullname: Kupesiz, Alphan email: akupesiz@akdeniz.edu.tr organization: Department of Pediatric Hematology, Faculty of Medicine, Akdeniz University, Antalya, Turkey |
| BookMark | eNqFkDtPwzAUhS1UJNrCP2DIyJLgRxI7CAZUlYdURCXKbN06N8LBSYqdVuq_J1WZGGC6dzjf0dE3IaO2a5GQS0YTRll-XSfgTYNlwinnCZUJpeyEjJmSIs5SJUdkTJlScZrS4oxMQqgppSrN5ZjczR3uoMcyekOHbbfxXY-2jZbRAnfoQjT8qw9wEAI2FqIXqDsfLaG32PbhnJxW4AJe_NwpeX-Yr2ZP8eL18Xl2v4gNz2UfgwLka5MVkiOUmCFHLMRaKJEaZCajUhQZZiJfc5lCIcpSGag4o0JlVVUVYkqujr3DvK8thl43Nhh0DlrstkHzvGA0E4zzIXpzjBrfheCx0sb2w9yu7T1YpxnVB2e61kdn-uBMU6kHZwOc_oI33jbg9_9ht0dsEIY7i14bZ1trwH3iXped_Rv_BtRBiUE |
| CitedBy_id | crossref_primary_10_12677_ACM_2023_1381856 crossref_primary_10_1039_D4OB00006D |
| Cites_doi | 10.1097/00006199-200105000-00009 10.1042/bj20021853 10.2144/fsoa-2020-0110 10.1155/2014/261761 10.1007/s12185-018-2411-9 10.1038/nrendo.2011.174 10.1016/S0140-6736(11)61452-9 10.1016/j.beem.2009.08.002 10.1111/cen.12185 10.1530/eje.0.1430319 10.1002/ajh.21416 10.1016/j.bbagen.2006.08.010 10.1016/j.clnu.2013.01.005 10.1089/thy.2009.0351 10.1007/s40291-018-0373-5 10.3109/10715762.2015.1004327 10.1042/BJ20090219 10.1080/03630269.2021.2003382 10.1530/eje.0.1330099 10.1096/fj.08-119370 10.1590/2359-3997000000309 10.1016/j.jpeds.2010.04.064 10.1016/B978-0-12-407681-5.00003-9 10.1002/pbc.20669 10.1007/s12011-014-9992-9 10.1530/acta.0.1140497 |
| ContentType | Journal Article |
| Copyright | 2022 Copyright © 2022. Published by Elsevier Inc. |
| Copyright_xml | – notice: 2022 – notice: Copyright © 2022. Published by Elsevier Inc. |
| DBID | AAYXX CITATION 7X8 |
| DOI | 10.1016/j.arcmed.2022.07.001 |
| DatabaseName | CrossRef MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1873-5487 |
| EndPage | 515 |
| ExternalDocumentID | 10_1016_j_arcmed_2022_07_001 S0188440922000741 |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M41 MO0 N9A NQ- O-L O9- OAUVE OD~ OO0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K UHS Z5R ~G- AAYXX AFCTW AGRNS CITATION RIG 7X8 |
| ID | FETCH-LOGICAL-c267t-a8ae2bc5972eade5e2ee93b3834ce1c507395e536b274a93dd8caf210385fff93 |
| ISSN | 0188-4409 1873-5487 |
| IngestDate | Sun Aug 24 04:00:56 EDT 2025 Thu Apr 24 22:57:17 EDT 2025 Tue Jul 01 02:48:40 EDT 2025 Tue Aug 26 16:31:53 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Glutathione peroxidase Thalassemia Hypothyroidism Selenoprotein P |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c267t-a8ae2bc5972eade5e2ee93b3834ce1c507395e536b274a93dd8caf210385fff93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-0598-4294 0000-0001-8827-5567 |
| PQID | 2691053122 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_2691053122 crossref_citationtrail_10_1016_j_arcmed_2022_07_001 crossref_primary_10_1016_j_arcmed_2022_07_001 elsevier_clinicalkey_doi_10_1016_j_arcmed_2022_07_001 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | July 2022 2022-07-00 20220701 |
| PublicationDateYYYYMMDD | 2022-07-01 |
| PublicationDate_xml | – month: 07 year: 2022 text: July 2022 |
| PublicationDecade | 2020 |
| PublicationTitle | Archives of medical research |
| PublicationYear | 2022 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Rayman (bib0009) 2012; 379 d'Arqom, GP, Savitri (bib0010) 2020; 6 Ozturk, Genc, Kupesiz (bib0013) 2015; 49 Alexandrides, Georgopoulos, Yarmenitis (bib0029) 2000; 143 Mashhadi, Heidari, Sepehri (bib0003) 2014; 8 Fibach, Dana (bib0018) 2019; 23 Asadov, Alimirzoeva, Mammadova (bib0001) 2018; 108 Schomburg, Schweizer, Holtmann (bib0014) 2003; 370 Contempre, Dumont, Denef (bib0022) 1995; 133 Jain (bib0006) 2014; 159 Schomburg (bib0008) 2011; 8 Goyens, Golstein, Nsombola (bib0020) 1987; 114 Stefanowicz, Talwar, O'Reilly (bib0028) 2013; 32 Haghpanah, Hosseini-Bensenjan, Sayadi (bib0005) 2021; 45 Sherief, Abd El-Salam, Kamal (bib0007) 2014; 2014 El Beshlawy, Hamdy, Kamel (bib0030) 2015; 6 Claster, Wood, Noetzli (bib0012) 2009; 84 Toulis, Anastasilakis, Tzellos (bib0023) 2010; 20 Bellinger, Raman, Reeves (bib0027) 2009; 422 Naithani, Chandra, Bhattacharjee (bib0031) 2006; 46 Cappellini, Cohen, Taher (bib0002) 2014 Burk, Hill, Motley (bib0015) 2006; 1760 Kohrle, Gartner (bib0032) 2009; 23 Federige, Romaldini, Miklos (bib0017) 2017; 61 Awadallah (bib0019) 2013; 60 Eshragi, Tamaddoni, Zarifi (bib0004) 2011; 2 Renko, Hofmann, Stoedter (bib0016) 2009; 23 Bulow Pedersen, Knudsen, Carle (bib0024) 2013; 79 Fung, Xu, Kwiatkowski (bib0025) 2010; 157 Kandhro, Kazi, Sirajuddin (bib0021) 2011; 57 Ayling (bib0026) 2014 Bartfay, Bartfay (bib0011) 2001; 50 Haghpanah (10.1016/j.arcmed.2022.07.001_bib0005) 2021; 45 Burk (10.1016/j.arcmed.2022.07.001_bib0015) 2006; 1760 Stefanowicz (10.1016/j.arcmed.2022.07.001_bib0028) 2013; 32 Alexandrides (10.1016/j.arcmed.2022.07.001_bib0029) 2000; 143 Rayman (10.1016/j.arcmed.2022.07.001_bib0009) 2012; 379 Awadallah (10.1016/j.arcmed.2022.07.001_bib0019) 2013; 60 Contempre (10.1016/j.arcmed.2022.07.001_bib0022) 1995; 133 Naithani (10.1016/j.arcmed.2022.07.001_bib0031) 2006; 46 Sherief (10.1016/j.arcmed.2022.07.001_bib0007) 2014; 2014 Schomburg (10.1016/j.arcmed.2022.07.001_bib0014) 2003; 370 Toulis (10.1016/j.arcmed.2022.07.001_bib0023) 2010; 20 Bellinger (10.1016/j.arcmed.2022.07.001_bib0027) 2009; 422 El Beshlawy (10.1016/j.arcmed.2022.07.001_bib0030) 2015; 6 Asadov (10.1016/j.arcmed.2022.07.001_bib0001) 2018; 108 Schomburg (10.1016/j.arcmed.2022.07.001_bib0008) 2011; 8 Bulow Pedersen (10.1016/j.arcmed.2022.07.001_bib0024) 2013; 79 Mashhadi (10.1016/j.arcmed.2022.07.001_bib0003) 2014; 8 Eshragi (10.1016/j.arcmed.2022.07.001_bib0004) 2011; 2 Renko (10.1016/j.arcmed.2022.07.001_bib0016) 2009; 23 Cappellini (10.1016/j.arcmed.2022.07.001_bib0002) 2014 Goyens (10.1016/j.arcmed.2022.07.001_bib0020) 1987; 114 Ozturk (10.1016/j.arcmed.2022.07.001_bib0013) 2015; 49 Kandhro (10.1016/j.arcmed.2022.07.001_bib0021) 2011; 57 Jain (10.1016/j.arcmed.2022.07.001_bib0006) 2014; 159 Bartfay (10.1016/j.arcmed.2022.07.001_bib0011) 2001; 50 d'Arqom (10.1016/j.arcmed.2022.07.001_bib0010) 2020; 6 Fibach (10.1016/j.arcmed.2022.07.001_bib0018) 2019; 23 Claster (10.1016/j.arcmed.2022.07.001_bib0012) 2009; 84 Federige (10.1016/j.arcmed.2022.07.001_bib0017) 2017; 61 Fung (10.1016/j.arcmed.2022.07.001_bib0025) 2010; 157 Kohrle (10.1016/j.arcmed.2022.07.001_bib0032) 2009; 23 Ayling (10.1016/j.arcmed.2022.07.001_bib0026) 2014 |
| References_xml | – volume: 114 start-page: 497 year: 1987 end-page: 502 ident: bib0020 article-title: Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism publication-title: Acta Endocrinol (Copenh) – volume: 20 start-page: 1163 year: 2010 end-page: 1173 ident: bib0023 article-title: Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis publication-title: Thyroid – volume: 23 start-page: 815 year: 2009 end-page: 827 ident: bib0032 article-title: Selenium and thyroid publication-title: Best Pract Res Clin Endocrinol Metab – volume: 133 start-page: 99 year: 1995 end-page: 109 ident: bib0022 article-title: Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism publication-title: Eur J Endocrinol – volume: 2 start-page: 189 year: 2011 end-page: 193 ident: bib0004 article-title: Thyroid function in major thalassemia patients: Is it related to height and chelation therapy? publication-title: Caspian J Intern Med – volume: 6 start-page: FSO628 year: 2020 ident: bib0010 article-title: Vitamin and mineral supplementation for beta-thalassemia during COVID-19 pandemic publication-title: Future Sci OA – volume: 32 start-page: 837 year: 2013 end-page: 842 ident: bib0028 article-title: Erythrocyte selenium concentration as a marker of selenium status publication-title: Clin Nutr – volume: 2014 year: 2014 ident: bib0007 article-title: Nutritional biomarkers in children and adolescents with Beta-thalassemia-major: An Egyptian center experience publication-title: Biomed Res Int – volume: 57 start-page: 575 year: 2011 end-page: 585 ident: bib0021 article-title: Effects of selenium supplementation on iodine and thyroid hormone status in a selected population with goitre in Pakistan publication-title: Clin Lab – volume: 159 start-page: 87 year: 2014 end-page: 98 ident: bib0006 article-title: Thyroid function and serum copper, selenium, and zinc in general U.S. population publication-title: Biol Trace Elem Res – volume: 79 start-page: 584 year: 2013 end-page: 590 ident: bib0024 article-title: Serum selenium is low in newly diagnosed Graves' disease: a population-based study publication-title: Clin Endocrinol (Oxf) – volume: 60 start-page: 85 year: 2013 end-page: 128 ident: bib0019 article-title: Protein antioxidants in thalassemia publication-title: Adv Clin Chem – year: 2014 ident: bib0002 article-title: Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT) – volume: 23 start-page: 245 year: 2019 end-page: 261 ident: bib0018 article-title: Oxidative Stress in beta-Thalassemia publication-title: Mol Diagn Ther – volume: 143 start-page: 319 year: 2000 end-page: 325 ident: bib0029 article-title: Increased sensitivity to the inhibitory effect of excess iodide on thyroid function in patients with beta-thalassemia major and iron overload and the subsequent development of hypothyroidism publication-title: Eur J Endocrinol – volume: 84 start-page: 344 year: 2009 end-page: 348 ident: bib0012 article-title: Nutritional deficiencies in iron overloaded patients with hemoglobinopathies publication-title: Am J Hematol – volume: 422 start-page: 11 year: 2009 end-page: 22 ident: bib0027 article-title: Regulation and function of selenoproteins in human disease publication-title: Biochem J – volume: 23 start-page: 1758 year: 2009 end-page: 1765 ident: bib0016 article-title: Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice publication-title: FASEB J – volume: 1760 start-page: 1789 year: 2006 end-page: 1793 ident: bib0015 article-title: Deletion of selenoprotein P upregulates urinary selenium excretion and depresses whole-body selenium content publication-title: Biochim Biophys Acta – volume: 6 start-page: 1 year: 2015 ident: bib0030 article-title: Urinary Iodine in Egyptian Patients with Thalassemia Major: A Focus on its Potential Contributing Impact on Consequent Hypothyroidism publication-title: J Mol Biomark Diagn – volume: 46 start-page: 780 year: 2006 end-page: 785 ident: bib0031 article-title: Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major publication-title: Pediatr Blood Cancer – volume: 370 start-page: 397 year: 2003 end-page: 402 ident: bib0014 article-title: Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues publication-title: Biochem J – volume: 157 start-page: 641 year: 2010 end-page: 647 ident: bib0025 article-title: Relationship between chronic transfusion therapy and body composition in subjects with thalassemia publication-title: J Pediatr – volume: 8 start-page: 1 year: 2014 end-page: 4 ident: bib0003 article-title: The selenium status in thalassemia patients in South East of iran publication-title: Int J Hematol Oncol Stem Cell Res – volume: 379 start-page: 1256 year: 2012 end-page: 1268 ident: bib0009 article-title: Selenium and human health publication-title: Lancet – volume: 50 start-page: 178 year: 2001 end-page: 183 ident: bib0011 article-title: Selenium and glutathione peroxidase with beta-thalassemia major publication-title: Nurs Res – volume: 45 start-page: 275 year: 2021 end-page: 286 ident: bib0005 article-title: The Prevalence of Hypothyroidism among Patients With beta-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies publication-title: Hemoglobin – volume: 61 start-page: 600 year: 2017 end-page: 607 ident: bib0017 article-title: Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study publication-title: Arch Endocrinol Metab – volume: 8 start-page: 160 year: 2011 end-page: 171 ident: bib0008 article-title: Selenium, selenoproteins and the thyroid gland: Interactions in health and disease publication-title: Nat Rev Endocrinol – start-page: 180 year: 2014 end-page: 199 ident: bib0026 article-title: Clinical biochemistry of nutrition publication-title: Clinical Biochemistry: Metabolic and Clinical Asp – volume: 108 start-page: 5 year: 2018 end-page: 21 ident: bib0001 article-title: beta-Thalassemia intermedia: a comprehensive overview and novel approaches publication-title: Int J Hematol – volume: 49 start-page: 309 year: 2015 end-page: 316 ident: bib0013 article-title: Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress publication-title: Free Radic Res – volume: 50 start-page: 178 year: 2001 ident: 10.1016/j.arcmed.2022.07.001_bib0011 article-title: Selenium and glutathione peroxidase with beta-thalassemia major publication-title: Nurs Res doi: 10.1097/00006199-200105000-00009 – volume: 57 start-page: 575 year: 2011 ident: 10.1016/j.arcmed.2022.07.001_bib0021 article-title: Effects of selenium supplementation on iodine and thyroid hormone status in a selected population with goitre in Pakistan publication-title: Clin Lab – volume: 370 start-page: 397 year: 2003 ident: 10.1016/j.arcmed.2022.07.001_bib0014 article-title: Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues publication-title: Biochem J doi: 10.1042/bj20021853 – volume: 6 start-page: FSO628 year: 2020 ident: 10.1016/j.arcmed.2022.07.001_bib0010 article-title: Vitamin and mineral supplementation for beta-thalassemia during COVID-19 pandemic publication-title: Future Sci OA doi: 10.2144/fsoa-2020-0110 – volume: 2014 year: 2014 ident: 10.1016/j.arcmed.2022.07.001_bib0007 article-title: Nutritional biomarkers in children and adolescents with Beta-thalassemia-major: An Egyptian center experience publication-title: Biomed Res Int doi: 10.1155/2014/261761 – volume: 108 start-page: 5 year: 2018 ident: 10.1016/j.arcmed.2022.07.001_bib0001 article-title: beta-Thalassemia intermedia: a comprehensive overview and novel approaches publication-title: Int J Hematol doi: 10.1007/s12185-018-2411-9 – volume: 8 start-page: 160 year: 2011 ident: 10.1016/j.arcmed.2022.07.001_bib0008 article-title: Selenium, selenoproteins and the thyroid gland: Interactions in health and disease publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2011.174 – volume: 379 start-page: 1256 year: 2012 ident: 10.1016/j.arcmed.2022.07.001_bib0009 article-title: Selenium and human health publication-title: Lancet doi: 10.1016/S0140-6736(11)61452-9 – volume: 23 start-page: 815 year: 2009 ident: 10.1016/j.arcmed.2022.07.001_bib0032 article-title: Selenium and thyroid publication-title: Best Pract Res Clin Endocrinol Metab doi: 10.1016/j.beem.2009.08.002 – volume: 6 start-page: 1 year: 2015 ident: 10.1016/j.arcmed.2022.07.001_bib0030 article-title: Urinary Iodine in Egyptian Patients with Thalassemia Major: A Focus on its Potential Contributing Impact on Consequent Hypothyroidism publication-title: J Mol Biomark Diagn – volume: 79 start-page: 584 year: 2013 ident: 10.1016/j.arcmed.2022.07.001_bib0024 article-title: Serum selenium is low in newly diagnosed Graves' disease: a population-based study publication-title: Clin Endocrinol (Oxf) doi: 10.1111/cen.12185 – volume: 143 start-page: 319 year: 2000 ident: 10.1016/j.arcmed.2022.07.001_bib0029 article-title: Increased sensitivity to the inhibitory effect of excess iodide on thyroid function in patients with beta-thalassemia major and iron overload and the subsequent development of hypothyroidism publication-title: Eur J Endocrinol doi: 10.1530/eje.0.1430319 – volume: 84 start-page: 344 year: 2009 ident: 10.1016/j.arcmed.2022.07.001_bib0012 article-title: Nutritional deficiencies in iron overloaded patients with hemoglobinopathies publication-title: Am J Hematol doi: 10.1002/ajh.21416 – volume: 1760 start-page: 1789 year: 2006 ident: 10.1016/j.arcmed.2022.07.001_bib0015 article-title: Deletion of selenoprotein P upregulates urinary selenium excretion and depresses whole-body selenium content publication-title: Biochim Biophys Acta doi: 10.1016/j.bbagen.2006.08.010 – volume: 32 start-page: 837 year: 2013 ident: 10.1016/j.arcmed.2022.07.001_bib0028 article-title: Erythrocyte selenium concentration as a marker of selenium status publication-title: Clin Nutr doi: 10.1016/j.clnu.2013.01.005 – volume: 2 start-page: 189 year: 2011 ident: 10.1016/j.arcmed.2022.07.001_bib0004 article-title: Thyroid function in major thalassemia patients: Is it related to height and chelation therapy? publication-title: Caspian J Intern Med – volume: 20 start-page: 1163 year: 2010 ident: 10.1016/j.arcmed.2022.07.001_bib0023 article-title: Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis publication-title: Thyroid doi: 10.1089/thy.2009.0351 – volume: 23 start-page: 245 year: 2019 ident: 10.1016/j.arcmed.2022.07.001_bib0018 article-title: Oxidative Stress in beta-Thalassemia publication-title: Mol Diagn Ther doi: 10.1007/s40291-018-0373-5 – volume: 49 start-page: 309 year: 2015 ident: 10.1016/j.arcmed.2022.07.001_bib0013 article-title: Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress publication-title: Free Radic Res doi: 10.3109/10715762.2015.1004327 – volume: 422 start-page: 11 year: 2009 ident: 10.1016/j.arcmed.2022.07.001_bib0027 article-title: Regulation and function of selenoproteins in human disease publication-title: Biochem J doi: 10.1042/BJ20090219 – volume: 8 start-page: 1 year: 2014 ident: 10.1016/j.arcmed.2022.07.001_bib0003 article-title: The selenium status in thalassemia patients in South East of iran publication-title: Int J Hematol Oncol Stem Cell Res – volume: 45 start-page: 275 year: 2021 ident: 10.1016/j.arcmed.2022.07.001_bib0005 article-title: The Prevalence of Hypothyroidism among Patients With beta-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies publication-title: Hemoglobin doi: 10.1080/03630269.2021.2003382 – year: 2014 ident: 10.1016/j.arcmed.2022.07.001_bib0002 – volume: 133 start-page: 99 year: 1995 ident: 10.1016/j.arcmed.2022.07.001_bib0022 article-title: Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism publication-title: Eur J Endocrinol doi: 10.1530/eje.0.1330099 – start-page: 180 year: 2014 ident: 10.1016/j.arcmed.2022.07.001_bib0026 article-title: Clinical biochemistry of nutrition publication-title: Clinical Biochemistry: Metabolic and Clinical Asp – volume: 23 start-page: 1758 year: 2009 ident: 10.1016/j.arcmed.2022.07.001_bib0016 article-title: Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice publication-title: FASEB J doi: 10.1096/fj.08-119370 – volume: 61 start-page: 600 year: 2017 ident: 10.1016/j.arcmed.2022.07.001_bib0017 article-title: Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study publication-title: Arch Endocrinol Metab doi: 10.1590/2359-3997000000309 – volume: 157 start-page: 641 year: 2010 ident: 10.1016/j.arcmed.2022.07.001_bib0025 article-title: Relationship between chronic transfusion therapy and body composition in subjects with thalassemia publication-title: J Pediatr doi: 10.1016/j.jpeds.2010.04.064 – volume: 60 start-page: 85 year: 2013 ident: 10.1016/j.arcmed.2022.07.001_bib0019 article-title: Protein antioxidants in thalassemia publication-title: Adv Clin Chem doi: 10.1016/B978-0-12-407681-5.00003-9 – volume: 46 start-page: 780 year: 2006 ident: 10.1016/j.arcmed.2022.07.001_bib0031 article-title: Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.20669 – volume: 159 start-page: 87 year: 2014 ident: 10.1016/j.arcmed.2022.07.001_bib0006 article-title: Thyroid function and serum copper, selenium, and zinc in general U.S. population publication-title: Biol Trace Elem Res doi: 10.1007/s12011-014-9992-9 – volume: 114 start-page: 497 year: 1987 ident: 10.1016/j.arcmed.2022.07.001_bib0020 article-title: Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism publication-title: Acta Endocrinol (Copenh) doi: 10.1530/acta.0.1140497 |
| SSID | ssj0008467 |
| Score | 2.3391042 |
| Snippet | Previous studies have measured selenium levels and glutathione peroxidase 3 (GPX3) activity in patients with thalassemia major (TM). However, Selenoprotein P... |
| SourceID | proquest crossref elsevier |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 508 |
| SubjectTerms | Glutathione peroxidase Hypothyroidism Selenoprotein P Thalassemia |
| Title | Elevated Selenoprotein P Levels in Thalassemia Major Patients |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0188440922000741 https://www.proquest.com/docview/2691053122 |
| Volume | 53 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6hVkJcEE_RApWRuFWOkn3E9hGhPgQEOKRSxWU1ux2riVI7SuJK5MBvZ3a9ttMHlHKxrJW9fszsPHa_-Zax9xbUwMjUxqrPMZbCJLGBHGjEGzUQQE7R76Iw-jo8PpGfTtVpN5Xtq0tWpmfXt9aV_I9UqY3k6qpk7yHZtlNqoHOSLx1JwnT8JxkfzPASfMjonEfpORcmZNT2vzgokEe6js9doeQSLyawP4JpuXCk_JOGwOk2_tmLsHQTaIDa6eIxReymvPTB5lFVYAvN-LYmt-WN6g_8WeC8W5VazMC3j3BZtfCaz9Ucl5N1XV0zPw_aGSYeeAdSbeciSRxS9rNNY1oz_walURuWUfXTDSer6hrOG_a7nkqY9tz2VOiIXDn33KrhuVfosq-5sRZc2ODWprruRbtedN-ts1OavM0pn3BbXfR-dVggF4R5rGv4oqbG0gMBb77Ln2KYa97chyjjJ-xxyC2iD7WiPGUPsHjGHo4CeuI5a_UluqIv0feo1peIzjf0JfL6EjX68oKdHB6MPx7HYfuM2PJhsoohBeTGUsbIHSpeIUfMhBGpkBYHVvk1WlRiaHgiIRNnZ6mFnDvGfJXneSZesq2iLPAVixLDaRQD2ERmUlGmQ4M6BSko3eYDULDDRPNDtA3c8m6Lk5n-mzB2WNzeNa-5Ve64XjX_Wjd1w-TpNCnPHfe9awSjyXi6FTEosKyWmg8pWiYvxPnuPd_lNXvUjYk3bGu1qPAthacrs-dV6zcXBY_n |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+Selenoprotein+P+Levels+in+Thalassemia+Major+Patients&rft.jtitle=Archives+of+medical+research&rft.au=Talibova%2C+Gunel&rft.au=Ozturk%2C+Zeynep&rft.au=Parlak%2C+Mesut&rft.au=Kupesiz%2C+Alphan&rft.date=2022-07-01&rft.issn=0188-4409&rft.volume=53&rft.issue=5&rft.spage=508&rft.epage=515&rft_id=info:doi/10.1016%2Fj.arcmed.2022.07.001&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_arcmed_2022_07_001 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0188-4409&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0188-4409&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0188-4409&client=summon |